Rubén Díez Punzano

Director/Board Member at Telum Therapeutics SL

Health Technology

Commercial Services

Profile

Rubén Díez Punzano founded Ikan Biotech SL in 2015, where he worked as Chief Executive Officer.
Mr. Díez Punzano also currently works at Telum Therapeutics SL, as Director.

Rubén Díez Punzano active positions

Companies	Position	Start
Telum Therapeutics SL Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez.	Director/Board Member	-

All active positions of Rubén Díez Punzano

Former positions of Rubén Díez Punzano

Companies	Position	End
Ikan Biotech SL Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain.	Chief Executive Officer	-

See the detail of Rubén Díez Punzano's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rubén Díez Punzano's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Ikan Biotech SL Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain.	Health Technology
Telum Therapeutics SL Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez.	Commercial Services